Mental Health, Neurodevelopmental Diagnoses in Publicly Insured Children on the Rise
By Lori Solomon HealthDay Reporter
WEDNESDAY, April 30, 2025 -- The percentage of publicly insured children receiving any mental health or neurodevelopmental disorder diagnosis significantly increased between 2010 and 2019, according to a study published online April 24 in the Journal of the American Medical Association.
Janet R. Cummings, Ph.D., from the Emory University Rollins School of Public Health in Atlanta, and colleagues estimated changes in the percentage of publicly insured children with mental health and/or neurodevelopmental disorder diagnoses. The analysis included administrative claims data (2010 to 2019) from 22 states for 29.9 million publicly insured children aged 3 to 17 years.
The researchers found that the percentage of publicly insured children with any diagnosed mental health or neurodevelopmental disorder increased from 10.7 percent in 2010 to 16.5 percent in 2019, with this trend remaining significant after adjusting for covariates (adjusted risk difference [aRD], 6.7 percentage points). For nine of the 13 diagnostic categories examined, statistically significant increases were seen, with the largest absolute increases seen for attention-deficit/hyperactivity disorder (aRD, 2.3 percentage points), trauma- and stressor-related disorders (aRD, 1.7 percentage points), anxiety disorders (aRD, 1.6 percentage points), autism spectrum disorders (aRD, 1.1 percentage points), depressive disorders (aRD, 0.9 percentage points), and other neurodevelopmental disorders (aRD, 2.6 percentage points).
"These findings highlight the need for access to appropriate services in safety net systems and other settings that serve this population," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
More Research Needed to Prepare People With Mental Illness for Menopause
THURSDAY, May 15, 2025 -- Few studies examine how people living with a mental illness may be best prepared for the menopause transition, considering both menopause symptoms and...
Exercise May Provide Protection for Childhood Psychiatric Conditions
THURSDAY, May 15, 2025 -- Physical activity (PA) and participation in organized sports may offer protective effects against childhood psychiatric conditions, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.